Synthesis, in vitro А-Glucosidase, and acetylcholinesterase inhibitory activities of novel Indol-Fused Pyrano[2,3-D]Pyrimidine compounds

被引:4
|
作者
Nguyen, Ha Thanh [1 ,2 ]
Tuan, Anh Nguyen [1 ]
Thi, Tuyet Anh Dang [1 ,2 ]
Van, Ket Tran [2 ,3 ]
Giang, Le-Nhat-Thuy [1 ,2 ]
Thi, Phuong Hoang [1 ]
Thi, Quynh Giang Nguyen [1 ,2 ]
Thi, Cham Ba [1 ,2 ]
Quang, Hung Tran [1 ,2 ]
Nguyen, Tuyen Van [1 ,2 ]
机构
[1] Vietnam Acad Sci & Technol VAST, Inst Chem, 18 Hoang Quoc Viet, Hanoi, Vietnam
[2] Grad Univ Sci & Technol, VAST, 18 Hoang Quoc Viet, Hanoi, Vietnam
[3] Mil Technol Acad, 236 Hoang Quoc Viet, Hanoi, Vietnam
关键词
Indol-fused pyrano[2; d; pyrimidine; Diabetes mellitus; alpha-glucosidase inhibitors; AChE inhibitors; Multicomponent-component reaction; BIOLOGICAL EVALUATION; COMPLICATIONS TRIAL/EPIDEMIOLOGY; MULTICOMPONENT SYNTHESIS; DIABETES INTERVENTIONS; ALPHA-AMYLASE; DERIVATIVES; DESIGN;
D O I
10.1016/j.bmcl.2023.129566
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, new indol-fused pyrano[2,3-d]pyrimidines were designed and synthesized. These products were obtained in moderate to good yields and their structures were assigned by NMR, MS, and IR analysis. Afterwards, the biological important of the products was highlighted by evaluating in vitro for alpha-glucosidase inhibitory activity as well as acetylcholinesterase (AChE) inhibitory activity. Eleven products revealed substantial inhibitory activity against alpha-glucosidase enzyme, among which, two most potent products 11d,e were approximately 93-fold more potent than acarbose as a standard antidiabetic drug. Besides that, product 11k exhibited good AChE inhibition. The substituents on the 5-phenyl ring, attached to the pyran ring, played a critical role in inhibitory activities. The biological potencies have provided an opportunity to further investigations of indol-fused pyrano[2,3-d]pyrimidines as potential anti-diabetic agents.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity
    Adly, Mina E.
    Gedawy, Ehab M.
    El-Malah, Afaf A.
    El-Telbany, Farag A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (05) : 747 - 756
  • [32] Synthesis, In Silico Prediction and In Vitro Evaluation of Antitumor Activities of Novel Pyrido[2,3-d]pyrimidine, Xanthine and Lumazine Derivatives
    El-Kalyoubi, Samar
    Agili, Fatimah
    MOLECULES, 2020, 25 (21):
  • [33] One-pot synthesis of 2H-pyrano[2,3-d]pyrimidine derivatives
    Mohammad Bayat
    Yadollah Bayat
    Soheila Shafei Asayesh
    Monatshefte für Chemie - Chemical Monthly, 2012, 143 : 479 - 483
  • [34] A NOVEL ONE-STEP SYNTHESIS OF PYRANO(2,3-D) PYRIMIDINES
    AHLUWALIA, VK
    SHARMA, HR
    TYAGI, R
    TETRAHEDRON, 1986, 42 (14) : 4045 - 4048
  • [35] PYRIDAZINES .26. A NOVEL SYNTHESIS OF PYRANO[2,3-D]PYRIDAZINES
    HEINISCH, G
    HOLZER, W
    NAWWAR, GAM
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 1986, 23 (01) : 93 - 96
  • [36] SYNTHESIS OF THE NOVEL PYRROLO[2,3-D]PYRIMIDINE ALKALOID RIGIDIN
    EDSTROM, ED
    WEI, Y
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 245 - ORGN
  • [37] SYNTHESIS OF A NOVEL PYRROLO[2,3-D]PYRIMIDINE ALKALOID, RIGIDIN
    EDSTROM, ED
    WEI, Y
    JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (02): : 403 - 407
  • [38] SYNTHESIS OF PYRIDO-[2,3-D]PYRIMIDINE AND PYRROLO-[2,3-D]PYRIMIDINE NUCLEOSIDES
    ITOH, T
    MELIKOHANJANIAN, RG
    ISHIKAWA, I
    KAWAHARA, N
    MIZUNO, Y
    OGURA, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S220 - S220
  • [39] Three-component one-pot synthesis of fused uracils - pyrano[2,3-d]pyrimidine-2,4-diones
    Palasz, Aleksandra
    MONATSHEFTE FUR CHEMIE, 2008, 139 (11): : 1397 - 1404
  • [40] Three-component one-pot synthesis of fused uracils – pyrano[2,3-d]‐pyrimidine-2,4-diones
    Aleksandra Pałasz
    Monatshefte für Chemie - Chemical Monthly, 2008, 139 : 1397 - 1404